The HTA was asked to provide information on the total number of organs received by HTA-licensed establishments, distinguishing between living and deceased donations; and also sharing the amount of human tissue received (in weight) by these establishments.
The HTA was asked to provide information on our social media policy and also to give a break down of our expenditure for our organisational accounts per calendar year (Facebook, Twitter).
The HTA was asked to provide information on the quality indicators for ovarian tissue preservation and transplantation for the purpose of fertility preservation, for patients who are undergoing cancer treatment. HTA was also questioned on the ongoing quality checks of post-cryopreservation tissues.
The HTA was asked to provide information on reportable incidents that took place in the 2017 calendar year.
The HTA was asked to provide details on the number of church officials currently working as representatives of the HTA.
The HTA was asked to provide information on its intranet software.
The HTA was asked to provide information regarding energy supply contracts.
The HTA was asked to provide details of any flight bookings made since January 2015.
The Human Tissue Act 2004 requires that the removal of tissue from the deceased for research within the scope of the Act must always be licensed, on specified premises, and that specific minimum requirements are met.
This means that if, for example, a person wishes to remove relevant material from a deceased organ donor for research ‘in connection with disorders, or the functioning, of the human body’, the removal must always take place on premises licensed by the HTA for that purpose.
The HTA was asked to provide information on spam and junk emails received
